Objective In the EU, approximately 200k men are diagnosed annually with prostate cancer, and this figure is likely to increase due to the ageing population, causing a considerable health care problem. Inherited genetic factors are important in this disease, for example the breast cancer predisposition genes BRCA1 and BRCA2 have been reported to increase significantly the risk of prostate cancer. The European IMPACT study (scheduled to begin in 2005) aims to put in place networks and infrastructures in 23 countries (18 in Europe) to identify a male population harbouring germline mutations in the BRCA1 and BRCA2 genes and recruit them into targeted screening programs for prostate cancer. IMPACT also aims to support future research into the targeted screening and clinical management of prostate cancer in high-risk individuals. The main goal of this proposal (AIDIT) is to stimulate co-operation with Associated Candidate Countries in relation to the IMPACT study. It is intended that a Specific Support Action (SSA) could provide the means to identify and recruit appropriate centres in the ACCs; stimulate the participation of research teams in ACCs and connect expertise in all collaborating countries in this area. Networking and dissemination of the latest results from ongoing prostate cancer screening studies are crucial elements of this proposal, which has the long-term aim of enabling centres in the ACCs to join the IMPACT study, thus establishing a larger consortium and research base. AIDIT is also aimed at raising the profile of the need to improve clinical management of prostate cancer, educating the relevant stakeholders, improving quality of life, reducing early mortality and reducing the financial burden of health care. It will consider relevant gender, ethical and societal issues and will support the implementation of FP6 and, in particular, the Combating Cancer topic of Thematic Priority 1. AIDIT can only occur under an EU SSA. Fields of science medical and health sciencesclinical medicineoncologyprostate cancersocial sciencessociologydemographymortalitymedical and health sciencesclinical medicineoncologybreast cancernatural sciencesbiological sciencesgeneticsmutation Programme(s) FP6-LIFESCIHEALTH - Life sciences, genomics and biotechnology for health: Thematic Priority 1 under the Focusing and Integrating Community Research programme 2002-2006. Topic(s) LSH-2004-3-3 - Promotion of cooperation with Associated Candidate Countries (ACC) Call for proposal FP6-2004-LIFESCIHEALTH-5 See other projects for this call Funding Scheme SSA - Specific Support Action Coordinator THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL EU contribution No data Address 123 Old Brompton Road LONDON United Kingdom See on map Links Website Opens in new window Total cost No data Participants (2) Sort alphabetically Sort by EU Contribution Expand all Collapse all POMERANIAN MEDICAL UNIVERSITY Poland EU contribution No data Address UL. RYBACKA 1 SZCZECIN See on map Links Website Opens in new window Total cost No data AKDENIZ UNIVERSITY Türkiye EU contribution No data Address DEPT. OF MEDICAL BIOLOGY AND GENETICS, FACULTY OF MEDICINE, AKDENIZ UNIVERSITY, ANTALYA See on map Links Website Opens in new window Total cost No data